| Literature DB >> 35590378 |
Yang-Yuan Qiu1,2, Qiao-Cheng Chang3, Jun-Feng Gao1, Ming-Jia Bao4, Hai-Tao Luo5, Jin-Ho Song6, Sung-Jong Hong7, Rui-Feng Mao1, Yun-Yi Sun1, Ying-Yu Chen1, Ming-Yuan Liu2, Chun-Ren Wang8, Xiao-Lei Liu9.
Abstract
BACKGROUND: Clonorchiasis, an infectious disease caused by the liver fluke Clonorchis sinensis, may lead to the development of liver and gallbladder diseases, and even cholangiocarcinoma (CCA). However, the pathogenesis, host-pathogen interaction, and diagnostic markers for clonorchiasis remain unclear.Entities:
Keywords: Amino acid metabolism; Biochemical indices; Biomarkers; Clonorchis sinensis; Plasma metabolomics
Mesh:
Substances:
Year: 2022 PMID: 35590378 PMCID: PMC9118806 DOI: 10.1186/s13071-022-05290-y
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 4.047
Fig. 1Changes in biochemical indices at different periods of Clonorchis sinensis infection. ALT, alanine aminotransferase; AST, aspartate transaminase; GGT, glutamyl transpeptidase; TBA, total bile acid; HDL, high density lipoprotein; CHE, cholinesterase; dpi, days post-infection. *P < 0.05, **P < 0.01, ***P < 0.001, C. sinensis-infected group (n = 9) compared to the control group (n = 9)
Fig. 2Scatter plots and loading plots for the predicted scores of the two components retained in the orthogonal partial least squares discriminant analysis (OPLS-DA) models for both negative electrospray ionization (ESI−) and positive (ESI+) electrospray ionization. a OPLS-DA model of metabolites in the different infection phases under ESI− mode. b OPLS-DA model of metabolites in the different infection phases under ESI+ mode. c OPLS-DA model of metabolites at 14 days post-infection (dpi) under ESI− mode. d Loading plot of OPLS-DA model of metabolites at 14 dpi under ESI− mode; red circle represents variable importance in projection (VIP) value > 1. e OPLS-DA model of metabolites at 14 dpi under ESI+ mode. f Loading plot of OPLS-DA model of metabolites at 14 dpi under ESI+ mode. Red circle represents differential metabolites and VIP value > 1
Analysis of top five metabolic pathways via MetaboAnalyst based on all identified differential metabolites in four phases
| Pathway name | Compound hits | Pathway impact | Metabolites | |
|---|---|---|---|---|
| 7 dpi | ||||
| Pyrimidine metabolism | 8/60 | 2.03E−06 | 0.199 | |
| Nitrogen metabolism | 4/39 | 2.65E−03 | 0.008 | |
| Aminoacyl-tRNA biosynthesis | 5/75 | 5.13E−03 | 0 | |
| Arginine and proline metabolism | 5/77 | 5.75E−03 | 0.120 | |
| Cyanoamino acid metabolism | 2/16 | 2.41E−02 | 0 | |
| 14 dpi | ||||
| Glycine, serine, and threonine metabolism | 11/48 | 1.79E−05 | 0.511 | |
| Aminoacyl-tRNA biosynthesis | 13/75 | 7.28E−05 | 0.169 | |
| Arginine and proline metabolism | 11/77 | 1.48E−03 | 0.218 | |
| Pantothenate and CoA biosynthesis | 6/27 | 1.92E−03 | 0.274 | |
| Pyrimidine metabolism | 9/60 | 2.86E−03 | 0.174 | |
| 28 dpi | ||||
| Phenylalanine metabolism | 2/45 | 2.70E−02 | 0.012 | 4-Hydroxycinnamic acid; 3-hydroxyphenylacetic acid |
| Pyrimidine metabolism | 2/60 | 4.59E−02 | 0.092 | Uridine; uracil |
| Biotin metabolism | 1/11 | 6.23E−02 | 0.203 | Biotin |
| Caffeine metabolism | 1/21 | 1.16E−01 | 0.031 | Xanthine |
| Sphingolipid metabolism | 1/25 | 1.36E−01 | 0 | Phytosphingosine |
| 63 dpi | ||||
| Valine, leucine, and isoleucine degradation | 2/40 | 2.16E−02 | 0 | |
| Glycine, serine, and threonine metabolism | 2/48 | 3.04E−02 | 0.023 | Betaine; |
| Aminoacyl-tRNA biosynthesis | 2/75 | 6.85E−02 | 0 | |
| Purine metabolism | 2/92 | 9.76E−02 | 0.044 | Xanthine; hypoxanthine |
| Caffeine metabolism | 1/21 | 1.16E−01 | 0.031 | Xanthine |
Compound hits represent differential metabolites/all metabolites in a pathway; dpi, days post-infection
Fig. 3Metabolic pathways of differential metabolite enrichment in the rabbits infected with Clonorchis sinensis at different periods. a Classification of metabolic pathways in four periods [7 days post-infection (dpi), 14 dpi, 28 dpi and 63 dpi]. Specific pathways at b 7 dpi. c 14 dpi. d 28 dpi. e 63 dpi
Fig. 4Correlation analysis of differential metabolites therein under four different periods. Different background colors represent different metabolic pathways; ↓, downregulated differential metabolite; ↑, upregulated differential metabolite
Baseline characteristics of patients and verification indices
| Total number of population = 30 | Control group | ||
|---|---|---|---|
| Sex, | |||
| Male | 5 (62.5) | 13 (59.1) | |
| Female | 3 (37.5) | 9 (40.9) | |
| Age (years) | 45.5 (24–65) | 47.0 (36–68) | 0.26 |
| ALB (g/l) | 43.8 ± 4.6 | 46.8 ± 4.5 | 0.12 |
| UA (μmol/l) | 268.1 ± 92.4 | 343.1 ± 152.4 | 0.20 |
| Harmful alcohol intake* | 0 | 0 | |
| Biochemical indices | |||
| TBA (μmol/l) | 3.6 ± 2.0 | 3.6 ± 1.9 | 0.96 |
| ALT (IU/l) | 18.1 ± 8.0 | 27.8 ± 10.7 | 0.03 |
| AST (IU/l) | 16.1 ± 3.8 | 27.4 ± 8.3 | 0.001 |
| GGT (IU/l) | 18.4 ± 2.3 | 29.6 ± 6.6 | < 0.000 |
| HDL (mmol/l) | 1.3 ± 0.2 | 1.1 ± 0.3 | 0.05 |
| CHE (IU/l) | 7945.0 ± 1597.2 | 8613.1 ± 1804.2 | 0.36 |
| Metabolites | |||
| | 225.6 ± 30.8 | 940.3 ± 213.3 | 0.003 |
| Hypoxanthine (ng/ml) | 5279.8 ± 578.6 | 9963.7 ± 761.0 | < 0.000 |
| | 149.9 ± 7.5 | 339.3 ± 24.7 | < 0.000 |
| 3-methylglutaric acid (ng/ml) | 32.6 ± 4.1 | 58.5 ± 12.9 | 0.07 |
| Glycodeoxycholic acid (ng/ml) | 298.9 ± 96.2 | 363.7 ± 82.3 | 0.62 |
| Xanthine (ng/ml) | 593.3 ± 46.3 | 622.8 ± 31.3 | 0.61 |
Numerical variables are shown as median (range) or mean ± SEM
Categorical variables are expressed n (%)
ALB albumin, UA Uric acid, TBA total bile acid, ALT alanine aminotransferase, AST aspartate transaminase, GGT glutamyl transpeptidase, HDL high density lipoprotein, CHE cholinesterase
*Harmful alcohol intake: > 20 g in women and > 30 g in men
Fig. 5Verification and correlation of biochemical indices and metabolites. a The levels of biochemical indices in human serum samples. b The contents of candidate diagnostic markers verified via targeted metabolomics. AUC, area under the curve; TBA, total bile acid; CHE, cholinesterase; HDL, high density lipoprotein; ALT, alanine aminotransferase; AST, aspartate transaminase; GGT, glutamyl transpeptidase. ns, non-significant; *P < 0.05, ***P < 0.001 compared to the control group
Fig. 6Systematic analysis of key differential metabolites and biochemical indices. a Heat map visualization of key differential metabolites and biochemical indices between healthy individuals and Clonorchis sinensis-infected patients. b Spearman’s correlation was conducted between key differential metabolites and biochemical indices. c The receiver-operator characteristic (ROC) curve of gamma-glutamyl transferase (GGT) and d-glucuronate. Positive and negative correlations are indicated using red and blue colors, respectively